(3,4-Difluorophenyl)(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)piperidin-1-yl)methanone结构式
|
常用名 | (3,4-Difluorophenyl)(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)piperidin-1-yl)methanone | 英文名 | (3,4-Difluorophenyl)(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)piperidin-1-yl)methanone |
|---|---|---|---|---|
| CAS号 | 1170229-29-4 | 分子量 | 359.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H15F2N3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | (3,4-Difluorophenyl)(4-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)piperidin-1-yl)methanone |
|---|
| 分子式 | C18H15F2N3O3 |
|---|---|
| 分子量 | 359.3 |
| InChIKey | DRHLKNWQRSLLAQ-UHFFFAOYSA-N |
| SMILES | O=C(c1ccc(F)c(F)c1)N1CCC(c2nnc(-c3ccco3)o2)CC1 |
|
实验名称:Modulation of AMPAR-stargazin complexes
来源:Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters
靶标:Stargazin (mouse)
External Id:WaveGuideAssay:441
|